Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.13 - $0.28 $494 - $1,065
-3,804 Reduced 9.26%
37,272 $5,000
Q2 2022

Aug 15, 2022

SELL
$0.21 - $0.38 $3,663 - $6,628
-17,443 Reduced 29.81%
41,076 $12,000
Q1 2022

May 16, 2022

BUY
$0.31 - $2.27 $18,140 - $132,838
58,519 New
58,519 $18,000

Others Institutions Holding STAB

About Statera Biopharma, Inc.


  • Ticker STAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,295,700
  • Description
  • Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...
More about STAB
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.